Amgen Statistics
NASDAQ: AMGNHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
435.64-0.66 (-0.15%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Amgen by the numbers
Amgen has a market capitalization of $235.64 billion based on 540.91M shares outstanding. Its trailing P/E ratio is 25.3, below the 4-company peer median of 27.2, and its forward P/E is 17.3. The stock trades 1.2% above its 50-day average and 13.6% above its 200-day average.
Average daily trading volume is 2.82M shares, or about $1.23 billion in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
AMGN valuation vs. peer median
| Metric | AMGN | Peer median | Difference |
|---|---|---|---|
| Market cap | $235.64B | $35.88B | +557% |
| P/E (TTM) | 25.3 | 27.2 | -7% |
| Forward P/E | 17.3 | 15.4 | +13% |
| Avg. volume | 2.82M | 1.81M | +56% |
Peer median across 8 companies: GILD, MRNA, ARGX, BIIB, RVMD, BNTX, EXEL, NBIX.
Valuation
- Market cap
- $235.64B
- P/E (TTM)
- 25.25
- Forward P/E
- 17.34
- Price / sales (latest FY)
- 6.41
- EPS (TTM)
- $17.25
- Shares outstanding
- 540.91M
Price and trading
- Previous close
- 436.30
- Open
- 443.05
- Day range
- 434.51 – 445.49
- 52-week range
- 312.39 – 483.99
- 52-week change
- +29.06%
- 50-day moving average
- 430.45
- 200-day moving average
- 383.40
- Beta
- —
- Volume
- 4.94M
- Average volume
- 2.82M
Dividends and events
- Annual dividend
- $9.94
- Dividend yield
- 2.28%
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 235.64B
- Pe
- 25.25
- Forward Pe
- 17.34
- Eps
- 17.25
- Dividend Yield
- 2.31%
- Dividend Rate
- 9.94
- Week52 High
- 483.99
- Week52 Low
- 312.39
- Avg Volume
- 2.82M
- Shares Outstanding
- 540.91M
- Ma50
- 430.45
- Ma200
- 383.40
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -9.99%
- Pct From52w Low
- 39.45%